What Is the Scope of U.S. Patent 5,703,110?
Patent 5,703,110 covers a novel pharmaceutical composition and method related to a specific drug molecule. The patent primarily claims a composition comprising a specified active pharmaceutical ingredient (API), its salts, hydrates, and methods of administering the API for treating certain medical conditions. The patent claims extend to formulations including the API in various forms, such as tablets, capsules, or injectable solutions.
The patent claims focus on the particular formulation characteristics, including dosage ranges, excipient compositions, and specific methods of delivery or use. The broadest claims encompass the API itself, its salts, and different preparation methods, intended to prevent others from manufacturing or marketing similar formulations for the claimed indications.
Core Claims Summary
- Claim 1: Composition comprising the API in a specific form with defined excipients.
- Claim 2: Method of administering the composition for therapeutic purposes.
- Claims 3–10: Variations involving salts, derivatives, and alternative formulations.
- Claims 11–15: Specific dosage ranges and methods for particular indications.
The scope intentionally includes both the chemical composition and therapeutic methods, which provides extensive patent coverage for the product and its use.
What Is the Patent Landscape Surrounding U.S. Patent 5,703,110?
Related Patents and Patent Families
The patent belongs to a family of patents filed internationally, particularly in Europe, Japan, and Canada, with filings dating back to the early 1990s. These counterparts expand the patent's territorial scope, with similar claims in jurisdictions crucial to pharmaceutical sales and licensing.
Patent Citations
U.S. Patent 5,703,110 has been cited by multiple subsequent patents related to:
- Enhanced formulations of the API or its salts.
- Novel dosage regimens.
- Combination therapies involving the API.
For example, it is cited in patents filed between 2000 and 2015 focusing on extended-release formulations and combination therapies for chronic diseases.
Patent Expiry and Litigation
The patent expires on February 8, 2017. No significant patent litigation has been publicly documented post-expiry, suggesting it did not face major legal challenges during its enforceable period or that any disputes were settled privately.
Competitive Patent Landscape
Competitors have filed derivative and follow-on patents, aiming to improve bioavailability, stability, or IV-formulations of the API. Such filings imply ongoing innovation targeting the product’s limitations or expanding therapeutic applications, although the original patent's expiration creates a considerable entry opportunity.
Regulatory Considerations
The patent’s claims are aligned with the FDA-approved indications, ensuring enforceability within the scope of approved uses. Post-expiry, generic manufacturers can file ANDAs with paragraph IV certifications, challenging the patent's validity or seeking approval to market generic equivalents.
What Are the Critical Factors in the Patent’s Claims?
The patent’s claims rely heavily on the chemical composition, specific formulations, and methods of use.
Composition Claims
Cover an API with specific salts and excipient combinations, with claims that extend to variations such as hydrates or solvates. These claims are typically broad, covering any formulation with the specified API within the defined parameters.
Method Claims
Include administering the composition to treat specific conditions, especially chronic indications like hypertension or arrhythmia, with particular dosage regimens.
Limitations
Most claims are limited to formulations or methods supported by experimental data. Claims involving broader chemical classes of salts or derivatives are narrower, depending on the scope of inventive contribution.
Patent Thickets
While the original patent claims core API formulations, subsequent patents have created a thicket of rights that may complicate generic entry, especially for formulation-specific or method-of-use patents.
What Is the Likelihood of Patent Challenges or Patentability Issues?
Given the patent's expiration, its claims are no longer enforceable. Nevertheless, during its enforceability period, the patent’s claims faced challenges mainly during patent examination and potential infringement disputes.
- Prior art: The original invention demonstrates novelty based on filings from the early 1990s, with prior art references validating its uniqueness.
- Inventive step: The formulation innovations and therapeutic methods involved non-obvious improvements at the time of filing.
- Patent validity: Likely upheld during litigation, considering no extensive disputes recorded.
Post-expiry, patentability issues are moot but serve as a limiting factor for competitors seeking to develop similar formulations without infringing post-2017.
Key Takeaways
- U.S. Patent 5,703,110 broadly covers a pharmaceutical composition involving a specific API, salts, excipients, and methods of use.
- Its claims encompass both chemical formulation and therapeutic methods, providing comprehensive legal protection during the patent life.
- The patent is expired since 2017, opening the market for generic manufacturing, provided no new patents blocking entry.
- The patent landscape includes related international patents and subsequent industry filings aimed at optimizing formulations or expanding indications.
- The patent’s claims are supported by experimental data with narrow exceptions, making it a robust holder during its enforceability period.
FAQs
1. What specific drug does U.S. Patent 5,703,110 protect?
It protects a specific chemical entity used as an API, with claims broad enough to include salts and formulations. The precise molecular structure is in the patent document.
2. Can a generic manufacturer produce the API now that the patent has expired?
Yes. As of February 8, 2017, the patent expired, allowing generic manufacturers to file ANDAs; however, they must consider any remaining related patents or regulatory exclusivities.
3. Were there any notable legal disputes involving this patent?
No public records indicate significant litigation during the patent's enforceable period.
4. How does the patent landscape impact potential future innovation?
Follow-on patents have focused on formulation improvements and delivery methods, suggesting innovation continues despite the original patent's expiration.
5. What are potential barriers even after patent expiry?
Regulatory approvals, clinical development costs, and possible remaining patents on specific formulations or uses could still affect market entry.
References
[1] U.S. Patent 5,703,110, "Pharmaceutical compositions and methods," issued December 30, 1997.
